P259 | IICIMED

In vitro activity of Bacillus against ESBL-Escherichia coli.

P259

Appl. Microbiol. 2022, 132, 2270–2279. 

In vitro and in vivo activity of new strains of Bacillus subtilis against ESBL‐producing Escherichia coli: an experimental study.


https://doi.org/10.1111/jam.15329

P258 | IICIMED

P258

Future Microbiol. 2022, 17, 1437-1443. 

Otomycosis caused by the cryptic and emerging species Aspergillus sydowii: two case reports.


https://doi.org/10.2217/fmb-2022-0137

P257 | IICIMED

P257

Med. Mycol. 2022, 60, myac021. 

GMC study group. Contribution of the anaerobic blood culture vial for the recovery of Candida glabrata: A retrospective multicentric study.


https://doi.org/10.1093/mmy/myac021

P256 | IICIMED

Evolution of the incidence of Enterobacteriaceae producing extended spectrum B-lactamase (E-ESBL) infections.

P256

Eur. J. Clin. Microbiol. Infect. Dis. 2022, 41, 1237-1243. 

Retrospective analysis of a large single cohort of Enterobacteriaceae producing extended-spectrum B-lactamase (E-ESBL) patients: incidence, microbiology, and mortality. 


https://doi.org/10.1007/s10096-022-04489-2

P255 | IICIMED

Invasive fungal diseases (IFDs) and related underlying conditions and their evolution (RESSIF network, France, 2012 to 2018).

P254 | IICIMED

Genome alignment of Diutina catenulata strains CBS565 and WY3-10-4.

P254

Mycopathologia. 2022, 187, 417-420.

De novo nanopore genome sequencing of the clinical Diutina catenulata type-strain CBS565.


https://doi.org/10.1007/s11046-022-00632-x

P253 | IICIMED

SNP-based unrooted phylogeny of 170 C. parapsilosis isolates.

P253

mBio. 2022, e0177722. 

Systematic analysis of copy number variations in the pathogenic yeast Candida parapsilosis identifies a gene amplification in RTA3 that is associated with drug resistance.


https://doi.org/10.1128/mbio.01777-22

P252 | IICIMED

Representation of the phylogenetic tree associated with fluconazole minimal inhibitory concentrations (MICs) and epidemiological data of 45 strains of Diutina catenulata.

P252

Clin. Microbiol. Infect. 2022

Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples.


https://doi.org/10.1016/j.cmi.2022.09.021

P251 | IICIMED

Colonies of P. blaschkeae (A) and P. bovis (B) microalgae strains grown on Sabouraud agar medium.

P251

Microorganisms. 2022, 10, 938.

Prototheca infections and ecology from a One Health perspective. 


https://doi.org/10.3390/microorganisms10050938

P250 | IICIMED

P250

Phytochem. Lett. 2022, 50, 57-60.

Amino ether analogues of 4,4′-dihydroxy-3-methoxy-6,7′-cyclolignan and their activity against drug-resistant bacteria. 


https://doi.org/10.1016/j.phytol.2022.05.004

P249 | IICIMED

Construction of CRISPR mutants for CgCRZ1.

P249

PLoS One 2022

CRISPR-Cas9 approach confirms Calcineurin-responsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata


https://doi.org/10.1371/journal.pone.0265777

P248 | IICIMED

Macroscopic features of the Aspergillus flavus clinical isolate after five days on Sabouraud dextrose agar at 28 °C.

P248

Rev. Iberoam. Micol. 2022.

Lethal destructive sinusopathy due to amphotericin B-resistant Aspergillus flavus: A case report. 


https://doi.org/10.1016/j.riam.2022.01.001

P247 | IICIMED

In vitro antifungal susceptibilities of 31 clinical Candida auris isolates, with categorical classification following US Centers for Disease Control and Prevention (CDC) cut-off values.

P247

Int. J. Antimicrob. Agents. 2022

Head-to-head comparison of CLSI, EUCAST, Etest and Vitek2 results for Candida auris susceptibility testing.


https://doi.org/10.1016/j.ijantimicag.2022.106558

P246 | IICIMED

Basic structure of a sterol with standard carbon numbering according to the IUPAC.

P246

Microorganisms. 2022, 10, 104. 

Impact of TR34/L98H, TR46/Y121F/T289A and TR53 alterations in azole‐resistant Aspergillus fumigatus on sterol composition and modifications after In Vitro exposure to itraconazole and voriconazole.


https://doi.org/10.3390/microorganisms10010104

P245 | IICIMED

Multiple alignments of Fks2 (β-1,3-glucan synthase catalytic subunit 2) nucleotide and amino acid sequences from C. glabrata resistant and susceptible strains.

P245

J. Antimicrob. Chemother. 2022, 77, 585–597. 

Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.


https://doi.org/10.1093/jac/dkab454

P244 | IICIMED

P244

Letter to the Editor, Quim. Nova 2022, 45, 1-3.

The Franco-Brazilian Network on Natural Products (FB2NP): a new network promoting cooperation and exchanges in natural products research. 


https://doi.org/10.21577/0100-4042.20170847

P242 | IICIMED

P242

Mycoses 2022, 65, 303–311.

Collateral consequences of agricultural fungicides on pathogenic yeasts: a One Health perspective to tackle azole resistance. 


https://doi.org/10.1111/myc.13404